Ileus: Clinical Trials

8 trials for Ileus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 21Completed 1

Follow Ileus: new trials by email Literature Review of Ileus trials Research Report on Ileus

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
Eluxadoline, Placebo - Irritable Bowel Syndrome
Phase 3CompletedFuriex Pharmaceuticals, Inc11462012-05-292018-07-30
The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section
Gum chewing - Paralytic Ileus
Phase 2 / Phase 3CompletedChiang Mai University1002010-05-012011-06-28
A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair
MOA-728, Placebo - Ileus
Phase 3CompletedBausch Health Americas, Inc.3742007-10-172019-09-04
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
alvimopan - Ileus
Phase 3CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)6602004-06-012016-01-11
Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery
Luminal stents, Minimally Invasive Surgical Bowel Diversion - Large Bowel Obstruction
Phase 3CompletedMemorial Sloan Kettering Cancer Center1802002-12-012007-12-10
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
Alvimopan - Ileus
Phase 3CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)5102002-01-012015-07-20
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus
Alvimopan - Ileus
Phase 3CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)6662001-12-012015-07-20
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
Alvimopan - Ileus
Phase 3CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4512001-03-012017-08-22

Narrower conditions

Colonic Pseudo-Obstruction (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hernia (1)  ·  Intestinal Diseases (1)  ·  Intestinal Pseudo-Obstruction (1)  ·  Irritable Bowel Syndrome (1)  ·  Signs and Symptoms, Digestive (1)

Broader conditions

Intestinal Obstruction (8)  ·  Digestive System Diseases (7)  ·  Gastrointestinal Diseases (7)  ·  Intestinal Diseases (7)  ·  Intestinal Pseudo-Obstruction (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Pathological Conditions, Anatomical (1)  ·  Signs and Symptoms (1)

Interventions

alvimopan (4)  ·  Chewing Gum (1)  ·  eluxadoline (1)  ·  methylnaltrexone (1)

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4)  ·  Bausch Health Americas, Inc. (1)  ·  Chiang Mai University (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (7)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Hans Gerdes, M.D. (1)  ·  Kittipat Charoenkwan, MD (1)  ·  Lindsey Mathew (1)

Results publications

PMID 20526599, PMID 15383800, PMID 15906123, PMID 16333556, PMID 19015469, PMID 26789872, PMID 28167156